MedTrace Logo

Evaluation of Procedural Analgesia for Liposonix Treatment

NCT01993238 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2014-04-29

Study results available
· View outcomes & findings →

Summary

The objectives of this study are to evaluate the safety and effectiveness of procedural analgesia for improvements in tolerability of treatment with the Liposonix System.

Conditions

  • Body Contouring

Interventions

DEVICE

Liposonix System (Model 2)

Treatment of subcutaneous adipose tissue of the abdomen using high intensity focused ultrasound (Liposonix System Model 2).

DRUG

Pre-treatment analgesia

Pre-treatment analgesia (combination of ondansetron, ketorolac, and hydromorphone)

Sponsors & Collaborators

  • Solta Medical

    lead INDUSTRY

Principal Investigators

  • Ronald Wheeland, MD

  • Reid Rubsamen, MD

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01993238 on ClinicalTrials.gov